Cedara Software Unveils B-CAD(TM) at RSNA 2004 - A Major Breakthrough in Breast Ultrasound Computer Assisted Detection
28 Noviembre 2004 - 7:45AM
PR Newswire (US)
Cedara Software Unveils B-CAD(TM) at RSNA 2004 - A Major
Breakthrough in Breast Ultrasound Computer Assisted Detection - Has
the potential to become a new standard of care in Women's Health by
greatly assisting Radiologists in diagnosing breast cancer and
thereby reducing the need for painful and expensive biopsies - Can
be deployed in Cedara's Multi-Modality CAD Workstation for Breast
Imaging giving seamless access to all forms of breast image data
and CAD technology TORONTO, Nov. 28 /PRNewswire-FirstCall/ --
Cedara Software Corp. (NASDAQ:CDSW/TSX:CDE), recently named Fastest
Growing Healthcare Company for 2004 by America's foremost market
research firm Frost and Sullivan, today unveiled its Cedara
B-CAD(TM) technology, a ground-breaking innovation in breast
ultrasound. B-CAD is designed to perform Computer Aided Detection
and Diagnosis. B-CAD uses a sophisticated image analysis scheme to
determine over 20 sonographic lesion characteristics, and an
advanced decision engine to help identify benign and malignant
lesions. Based on the pioneering 1995 study on solid breast nodules
by Dr. A. Thomas Stavros et al, and reviewed by Dr. Stavros using
an immense database of biopsy-correlated breast ultrasound data,
B-CAD can provide the radiologist with CAD information on the
clinically relevant characteristics and features of the target of
interest as well as the probability that a target lesion is either
benign or malignant. B-CAD has the potential to reduce operator
variability in breast ultrasound and provide the Radiologist with
valuable insight when determining the correct BI-RADS category for
a lesion. B-CAD can be seamlessly integrated with PACS and
Mammography workflows, and can be used in conjunction with live
ultrasound through video acquisition solutions such as DICOMIT
Information Manager(TM) or Cedara I-AcquireVideo(TM). B-CAD is
available to OEMs for integration with imaging systems, or
inclusion in next-generation ultrasound equipment. B-CAD provides
ultrasonographers with a new tool in the diagnosis of breast
cancer, can promote the greater adoption of breast ultrasound, and
will be a catalyst for the emergence of routine breast cancer
screening using ultrasound. "The combination of B-CAD with Cedara's
multi-modality CAD workstation is a phenomenal step forward for
breast imaging" stated Jeff Collins, CEO of Medipattern Corporation
- Cedara's partner in breast imaging and pioneer of the B-CAD
technology, "The combination of CAD systems for Mammography, MRI
and Ultrasound in one streamlined package is an industry first, and
makes Cedara's I-ReadMammo the preeminent solution for breast
imaging." Cedara I-ReadMammo provides unprecedented viewing
capabilities for Mammography and multi-modality breast data, and
works with all the major brands of imaging equipment. The inclusion
of B-CAD completes its roster of CAD solutions for mainstream
breast imaging modalities, and makes the concept of a
multi-modality CAD workstation for breast imaging a reality. "B-CAD
is the first ultrasound CAD to be demonstrated at RSNA and is an
amazing technology that can benefit women worldwide," stated Chris
Barlow, Cedara's Director of Business Development. "It is the most
sophisticated and advanced system for breast ultrasound, and can
change how breast cancer is found and diagnosed. B-CAD is available
for immediate OEM integration, and we are working to find partners
from all areas of breast ultrasound and oncology to help bring this
hugely positive advancement to market." Cedara's B-CAD prototype
can be seen in concert with Cedara I-ReadMammo at the 2004
Radiological Society of North America 90th Scientific Assembly and
Annual Meeting (RSNA), held November 28 to December 3 in Chicago.
B-CAD availability for clinical use is subject to regulatory
clearance. For more information about Cedara's complete range of
medical imaging products, visit the Cedara website at
http://www.cedara.com/. Or contact: Jacques Cornet, Vice President
of Marketing & Operations (905) 672-2100 ext. 2564 Email: For
investor-related inquiries, contact: Brian Pedlar, Chief Financial
Officer (905) 672-2100 ext. 2015 Email: About Cedara Software:
Cedara Software Corp. is a leading independent provider of medical
imaging technologies. Cedara software is deployed in hospitals and
clinics worldwide and is licensed by many of the world's leading
medical device and healthcare information technology companies.
Approximately 28,000 medical imaging systems and 6,400 Picture
Archiving and Communications System (PACS) workstations have been
licensed to date. Cedara recently acquired eMed Technologies
Corporation, widely known as a provider of innovative PACS and
teleradiology solutions that have been installed in over 2,000
hospitals and imaging centers. Cedara is quite unique in that it
has technologies and expertise that span all the major digital
imaging modalities including computed tomography (CT), magnetic
resonance imaging (MRI), digital X-ray, mammography, ultrasound,
echo-cardiology, angiography, nuclear medicine, positron emission
tomography (PET) and fluoroscopy. Furthermore, the Company's
medical imaging offerings are used in all aspects of clinical
workflow including the capture of a patient's digital image; the
archiving, communication and manipulation of digital images;
sophisticated clinical applications to analyze digital images; and
even the use of imaging in minimally-invasive surgery. Certain
statements contained in this news release are forward-looking
within the meaning of securities laws and are based on current
expectations that are subject to a number of assumptions,
uncertainties and risks, and there are actual results may differ
materially from what is currently expected. These assumptions,
uncertainties and risks include, but are not limited to: the
management of the growth of the Company, dependence on key
personnel of the Company, competitive pressures (including price
competition), changes in market activity, risks associated with
international operations, the development of new products and
services, the enhancement of existing products and services, the
introduction of competing products having technological and/or
other advantages, the dependence on key customers, regulatory
changes to the health care industry, seasonality, economic and
political conditions and adequate protection of the proprietary
interests of the Company. Further information about these risks and
uncertainties can be found in the continuous disclosure documents
filed from time to time by Cedara with the securities regulatory
authorities, which documents are available at
http://www.sedar.com/. All trademarks appearing in this release are
the property of Cedara Software Corp. DATASOURCE: Cedara Software
Corp. CONTACT: Contact: Jacques Cornet, Vice President of Marketing
& Operations, Cedara Software Corp., (905) 672-2100 ext. 2564,
; For investor-related inquiries, contact: Brian Pedlar, Chief
Financial Officer, (905) 672-2100 ext. 2015, Email: ; To request a
free copy of this organization's annual report, please go to
http://www.newswire.ca/ and click on reports@cnw.
Copyright